Pfizer to spinoff, merge off-patent drugs unit with Mylan
By Michael Erman and Ankur BanerjeeJuly 29 (Reuters) - Pfizer Inc has agreed to spin off its off-patent branded drugs business and combine it with generic...
By Michael Erman and Ankur BanerjeeJuly 29 (Reuters) - Pfizer Inc has agreed to spin off its off-patent branded drugs business and combine it with generic...